PET helps predict esophageal cancer patients' response to treatment

02/28/2011 | HealthImaging.com

A study published in the Journal of Nuclear Medicine found that textural analysis of tumors based on 18F-FDG PET images proved effective in differentiating among patients with esophageal cancer who were nonresponders, partial responders and complete responders to combined radiochemotherapy. "Although only 18F-FDG images in esophageal cancer have been considered here, clearly the same indices applied in other PET radiotracer studies in the same or different tumor types may help create even stronger links between imaging and underlying tumor biology," researchers concluded.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC